WEDNESDAY, SEPTEMBER 28, 2016

Common antibiotic may solve multidrug-resistant bacterial infections

Common antibiotic may solve multidrug-resistant bacterial infections | Courtesy of angelfire.com

A team of scientists from the University of California, Skaggs School of Pharmacy and Pharmaceutical Sciences and San Diego School of Medicine announced that azithronmycin, a common antibiotic, may solve multidrug-resistant bacteria concerns.

This common drug may effectively kill the bacteria that causes multidrug-resistant bacteria. Azithromycin is commonly prescribed in the US for strep throat and sinusitis. When the scientists tested the drug under specific conditions very similar to the human body’s natural antimicrobial factors, the treatment proved efficient.

These new findings could provoke a rapid review of the health industry’s current standard of treatment for patients with multridrug-resistant illnesses.

"Unquestioning adherence to a single standardized lab practice may be keeping doctors from considering potentially life-saving antibiotics -- therapies that are proven safe and readily available in any hospital or pharmacy," Dr. Victor Nizet, senior author and professor of pediatrics and pharmacy, said. "While bacterial agars and testing media are useful in providing consistency for hospital laboratories around the world, the actual infection is taking place in the blood and tissues of the patient, and we know the action and potency of drugs can change quite dramatically in different surroundings."

Further details are available in the June 10 issue of EBioMedicine.

Organizations in this story

Skaggs School of Pharmacy and Pharmaceutical Sciences 9500 Gilman Dr San Diego, CA 92093

Get notified the next time we write about Skaggs School of Pharmacy and Pharmaceutical Sciences!